Bausch + Lomb IPO Opens Higher After Weak Pricing
2022.05.06 19:42
Bausch + Lomb (BLCO) IPO Opens Higher After Weak Pricing
Today’s IPO for Bausch + Lomb Corporation (BLCO) opened for trading at $18.50 after pricing 35,000,000 common shares at a public offering price of $18.00 per share, below the expected range.
Morgan Stanley (NYSE:MS) and Goldman Sachs & Co (NYSE:GS). LLC are acting as joint lead book-running managers for the IPO. Citigroup (NYSE:C), J.P. Morgan, Barclays (LON:BARC), BofA Securities, Guggenheim Securities, Jefferies, Evercore ISI, Wells Fargo (NYSE:WFC) Securities and Deutsche Bank (ETR:DBKGn) Securities are acting as joint book-running managers for the IPO, and DNB Markets, HSBC, Truist Securities, AmeriVet Securities, Loop Capital Markets, Ramirez & Co., Inc., R. Seelaus & Co., LLC, Siebert Williams Shank and Stern are acting as co-managers for the IPO.
Bausch + Lomb Corporation is being spun-out of Bausch Health Companies Inc. (NYSE:BHC).
Bausch + Lomb a leading global eye health business, dedicated to protecting and enhancing the gift of sight for millions of people around the world.
